Hong Cai - Independent Consultant - Self-employed | LinkedIn
HCP Fact Sheet
Thermo Fisher Scientific to Acquire Point-of-Care Molecular Diagnostics Provider Mesa Biotech
Slone Partners Places Ingo Chakravarty as President & CEO at Mesa Biotech
Accula SARS-CoV-2 Test - Patient Fact Sheet
Thermo Fisher Buys Mesa Biotech for a Total Deal of $550 Million | BioSpace
Accula™ SARS-CoV-2 Test
Thermo Fisher completes Mesa Biotech acquisition - MassDevice
Thermo Fisher nets hand-held COVID-19 test maker Mesa Biotech with $550M deal | Fierce Biotech
QIAGEN - Diagnostic companies are stepping up together to address the need for #COVID19testing. This graphic shows available COVID-19 tests supported by BARDA, from QIAGEN, Mesa Biotech, Inc., Cepheid, GenMark Diagnostics, Inc .,
Thermo Fisher acquires Mesa Biotech | Drug Discovery News
Thermo Fisher Scientific to acquire Mesa Biotech, gaining COVID-19 testing platform
Accula SARS-CoV-2 Test EUA
Mesa Biotech - Crunchbase Company Profile & Funding
Mesa Biotech, Inc. | LinkedIn
Designing for simplicity: lessons from Mesa Biotech for microfluidic entrepreneurs and early-stage companies - Lab on a Chip (RSC Publishing) DOI:10.1039/D2LC00081D
Thermo Fisher Acquires Point-of-Care Molecular Diagnostics Provider Mesa Biotech - Industry News - mobile.Labmedica.com
Medical Countermeasures | USA Public Health Security
Mesa Biotech Receives Emergency Use Authorization from FDA for a 30 Minute Point of Care Molecular COVID-19 Test
Mesa Biotech Launches Molecular Test System at AACC 2019 - AACC 2019 - mobile.Labmedica.com
Mesa Biotech Opens Manufacturing Facility to Meet Flu Diagnosis Needs - Pharmaceutical Processing World
Mesa Biotech-Accula SARS-CoV-2-Instructions For Use
Articles about Mesa Biotech, Inc
Mesa Biotech Receives ISO 13485 Quality Certification
